Literature DB >> 31270280

Autoimmune hepatitis, fatty liver, and Fukushima.

Atsushi Takahashi1, Hiromasa Ohira1.   

Abstract

The use of direct antiviral agents (DAAs) for hepatitis C virus has led to a paradigm shift from viral hepatitis to non-viral disease. Autoimmune hepatitis (AIH) remains to be an issue in liver disease after the DAAs era. Moreover, fatty liver had been increasing in incidence and has attracted attention because of its risk for hepatocellular carcinoma. In 2011, the Great East Japan Earthquake, with the associated tsunami and accident at Fukushima Daiichi Nuclear Power Plant, has changed the lifestyle of residents in Fukushima prefecture. In this manuscript, we outlined the recent topics about AIH, fatty liver, and Fukushima.

Entities:  

Keywords:  autoimmune hepatitis; non-alcoholic fatty liver disease; the Fukushima Heath Management Survey; the Great East Japan Earthquake

Mesh：

Year:  2019        PMID： 31270280      PMCID： PMC6760916          DOI： 10.5387/fms.2019-13

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN： 0016-2590


  42 in total

1.  Nonalcoholic fatty liver disease is associated with cognitive function in adults.

Authors:  Sang Won Seo; Rebecca F Gottesman; Jeanne M Clark; Ruben Hernaez; Yoosoo Chang; Changsoo Kim; Kyoung Hwa Ha; Eliseo Guallar; Mariana Lazo
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

2.  Autoimmune hepatitis: Diagnosis and treatment guide in Japan, 2013.

Authors:  Morikazu Onji; Mikio Zeniya; Kazuhide Yamamoto; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2014-04       Impact factor: 4.288

3.  Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis.

Authors:  Kalliopi Zachou; Pinelopi Arvaniti; Kalliopi Azariadis; Vasiliki Lygoura; Nikolaos K Gatselis; Aggeliki Lyberopoulou; George K Koukoulis; George N Dalekos
Journal:  Hepatol Res       Date:  2018-10-18       Impact factor: 4.288

4.  Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients.

Authors:  Hiep Nguyen Canh; Kenichi Harada; Hirofumi Ouchi; Yasunori Sato; Koichi Tsuneyama; Masayoshi Kage; Masayuki Nakano; Kaname Yoshizawa; Atsushi Takahashi; Masanori Abe; Jong-Hon Kang; Kazuhiko Koike; Ayano Inui; Tomoo Fujisawa; Akinobu Takaki; Teruko Arinaga-Hino; Takuji Torimura; Yoshiyuki Suzuki; Keiichi Fujiwara; Mikio Zeniya; Hiromasa Ohira; Atsushi Tanaka; Hajime Takikawa
Journal:  J Clin Pathol       Date:  2017-04-20       Impact factor: 3.411

5.  Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis.

Authors:  Albert J Czaja; K V Narayanan Menon; Herschel A Carpenter
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

6.  Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.

Authors:  Kaname Yoshizawa; Akihiro Matsumoto; Tetsuya Ichijo; Takeji Umemura; Satoru Joshita; Michiharu Komatsu; Naoki Tanaka; Eiji Tanaka; Masao Ota; Yoshihiko Katsuyama; Kendo Kiyosawa; Masanori Abe; Morikazu Onji
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

7.  Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis.

Authors:  J E Hegarty; K T Nouri Aria; B Portmann; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

8.  Study protocol for the Fukushima Health Management Survey.

Authors:  Seiji Yasumura; Mitsuaki Hosoya; Shunichi Yamashita; Kenji Kamiya; Masafumi Abe; Makoto Akashi; Kazunori Kodama; Kotaro Ozasa
Journal:  J Epidemiol       Date:  2012-08-25       Impact factor: 3.211

9.  Effects of lifestyle on hepatobiliary enzyme abnormalities following the Fukushima Daiichi nuclear power plant accident: The Fukushima health management survey.

Authors:  Atsushi Takahashi; Tetsuya Ohira; Kanako Okazaki; Seiji Yasumura; Akira Sakai; Masaharu Maeda; Hirooki Yabe; Mitsuaki Hosoya; Akira Ohtsuru; Yukihiko Kawasaki; Hitoshi Suzuki; Michio Shimabukuro; Yoshihiro Sugiura; Hiroaki Shishido; Yoshimitsu Hayashi; Hironori Nakano; Gen Kobashi; Kenji Kamiya; Hiromasa Ohira
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

10.  Non-alcoholic fatty liver disease in patients with autoimmune hepatitis.

Authors:  Atsushi Takahashi; Teruko Arinaga-Hino; Hiromasa Ohira; Kazumichi Abe; Takuji Torimura; Mikio Zeniya; Masanori Abe; Kaname Yoshizawa; Akinobu Takaki; Yoshiyuki Suzuki; Jong-Hon Kang; Nobuhiro Nakamoto; Tomoo Fujisawa; Atsushi Tanaka; Hajime Takikawa
Journal:  JGH Open       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.